These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6389475)

  • 1. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
    Shimada K; Matsuda T; Inamatsu T; Urayama K
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():325-30. PubMed ID: 6389475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe depletion of vitamin-K-dependent clotting factors during postoperative latamoxef therapy.
    MacLennan FM; Ah-See AK; Wong AE; Anderson JA; Bennett B
    Lancet; 1983 May; 1(8335):1215. PubMed ID: 6134006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acquired coagulopathy caused by administration of parenteral broad-spectrum antibiotics].
    Kikuchi S; Ando A; Minato K
    Rinsho Byori; 1991 Jan; 39(1):83-90. PubMed ID: 1901116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cephem antibiotics and alcohol metabolism: (1) Disulfiram-like reaction resulting from intravenous administration of cephem antibiotics].
    Yanagihara M; Okada K; Nozaki M; Tsurumi K; Fujimura H
    Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):551-60. PubMed ID: 6290355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
    Schäfer H; Naber K; Adam D
    Arzneimittelforschung; 1989 Sep; 39(9):1156-62. PubMed ID: 2590268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephem antibiotics and alcohol metabolism.
    Yanagihara M; Okada K; Nozaki M; Tsurumi K; Fujimura H
    Jpn J Antibiot; 1985 Mar; 38(3):634-42. PubMed ID: 3861880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 9. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC
    Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cefotaxime on intestinal flora and bleeding diathesis in infants and neonates, compared with other beta-lactams.
    Sunakawa K; Akita H; Iwata S; Sato Y
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():317-24. PubMed ID: 6094459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
    Clark J; Hochman R; Rolla AR; Thomas S; Miller DG; Kaldany A; D'Elia JA
    Clin Exp Dial Apheresis; 1983; 7(3):177-90. PubMed ID: 6671350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
    Baxter JG; Marble DA; Whitfield LR; Wels PB; Walczak P; Schentag JJ
    Ann Surg; 1985 Jan; 201(1):96-102. PubMed ID: 3966831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole.
    Hooper CA; Haney BB; Stone HH
    Lancet; 1980 Jan; 1(8158):39-40. PubMed ID: 6101371
    [No Abstract]   [Full Text] [Related]  

  • 16. Moxalactam, bleeding, and renal insufficiency.
    D'Elia JA; Kaldany A; Miller DG; Yoburn DC; Kaye WA
    JAMA; 1983 Mar; 249(12):1565. PubMed ID: 6219234
    [No Abstract]   [Full Text] [Related]  

  • 17. [Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol].
    Nakahata H; Hirai Y; Kumasaka Y; Miyazawa T; Nakamura T; Imamura K; Makino I; Takebe K; Kudo H
    Jpn J Antibiot; 1987 Jul; 40(7):1294-8. PubMed ID: 3479623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cephalosporin induced coagulopathies.
    Seeler RA; Reitan J
    IMJ Ill Med J; 1984 Nov; 166(5):351-3. PubMed ID: 6150914
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
    Weitekamp MR; Caputo GM; Al-Mondhiry HA; Aber RC
    J Antimicrob Chemother; 1985 Jul; 16(1):95-101. PubMed ID: 4044467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on oxacephem antibiotics: comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
    Uchida K; Matsubara T; Hirauchi K
    Jpn J Pharmacol; 1989 Jul; 50(3):283-8. PubMed ID: 2761130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.